Tetanus Articles
Vietnam: Vaccine Production
9 February 1998
1997: Another Good Year For New Chemical Entities
6 January 1998
Euro CPMP Plenary Meeting In October
12 November 1997
NAV Expects Certiva Approval By End-97
16 October 1997
Euro Union CPMP September Meeting
8 October 1997
Stock Comment Tokyo
2 October 1997
Multinationals Accused Of SL "Vaccines Panic"
16 September 1997
Proteus Fights Back With Solid Pipeline
20 August 1997
First Approval For SB's Infanrix Hep B
4 August 1997
Proteus More Confident At Fiscal Year-End
1 July 1997
NAV Combination Vaccine
26 June 1997
FDA Panel Fails To Back PMC's TriHIBit Vaccine
12 June 1997
Sweden Approves NAV's Pertussis Vaccine
24 April 1997
FDA To Review Lederle's DTaP-Hib
25 March 1997
SB's Infanrix Licensed In USA
10 February 1997
No Major Changes To Be Made At Rhone-Poulenc
10 February 1997
Medeva Takes On Single Isomer Methylphenidate
27 January 1997
1st Launch Of Merck's Comvax
27 January 1997
EU Backs 125 Biomed Research Projects
27 January 1997
Record Number Of New Chemical Entities In 1996
20 January 1997
Chiron Behring To Market NAV's DTaP Vaccines
16 December 1996
Pasteur Merieux Connaught Presents Strategy, Forecasts
9 December 1996
First Approval Of SB's Infanrix-DTPa+Hib
28 October 1996
PLA Filed For Chiron's Pertugen
7 October 1996
DTaP Plus Polio Vaccine Cleared In Denmark
7 October 1996
Improving Vaccines Against Pneumococcal Disease
30 September 1996
North American Vaccine And Abbott Laboratories Sign DTPa Agreement
2 September 1996
SmithKline Beecham: A Leader In Spanish Market
19 August 1996
First Acellular DTP Vaccine Licensed For Infants In USA
12 August 1996
SB's Tritanrix HB Cleared By EMEA
5 August 1996
FDA Recommend Approval Of SKB's Infanrix
22 July 1996
-North American Vaccine Gets Swedish Approval
19 February 1996
OPV Must Have Heat-Sensitive Label
29 January 1996
SB's Infanrix gets new marketing clearance
22 January 1996
New And Lucrative Human Vaccines Market Emerging
18 December 1995
North American Vaccine's DTPa-IPV
30 October 1995
SmithKline Beecham: Infranrix launch
11 September 1995
Developments In Iranian Health Care Sector
4 September 1995
Medeva Acquires US Vaccines
10 July 1995
German Vaccination Woes
17 April 1995
Vaccine News From ECCMID
3 April 1995
Indication Extension For SB's Infanrix
27 March 1995
Highlights Of SmithKline's R&D Portfolio
2 January 1995
IGIV: Is Self-Sufficiency Possible In The EU?
21 November 1994
Conditions Imposed On Cyanamid Purchase
21 November 1994
Biocine Meningococcal Vaccine Trials Start In UK
14 November 1994
Diftavax Launch In UK
24 October 1994
SmithKline Vaccine Results
17 October 1994
Medeva/SmithKline Vaccine Alliance
26 September 1994
HibTITER Approved For Mixing With DTP
22 August 1994
AHP Bid For Cyanamid Will Broaden Product Range
15 August 1994
Prenatal Vaccines Under Investigation In USA
25 July 1994
Takeda Warned By FDA Over Manufacturing Practices
18 July 1994
GALIEN AWARD
20 June 1994
MERIEUX VACCINE NEWS
13 June 1994
COMBINING VACCINES FOR EUROPE
30 May 1994
WHO: MANAGEMENT BY OBJECTIVES
9 May 1994
MERCK AND PASTEUR-MERIEUX VENTURE APPROVED IN EU
11 April 1994
CONNAUGHT'S PENTA VACCINE APPROVED
28 March 1994
NIH DEFENDS TRIALS OF PERTUSSIS VACCINE
21 March 1994
MERIEUX LAUNCHES VACCINE IN FRANCE
21 February 1994
UK PRODUCT NEWS IN BRIEF
7 February 1994
VACCINE NEWS IN BRIEF
17 January 1994
BIOCINE'S VACCINE PIPELINE
25 October 1993
CPMP APPROVES LEDERLE'S HIBTITER
25 October 1993
BUDGET BILL AND VACCINE COMP
23 August 1993
TETANUS AND THE ELDERLY
9 August 1993
CHILDHOOD VACCINATION IN THE USA: A SURVEY
28 June 1993
LEDERLE-PRAXIS APPROVAL
19 April 1993
PASTEUR MERIEUX VACCINE DEVELOPMENTS
19 April 1993
WHO ACTS TO PREVENT EX-USSR VACCINE CRISIS
19 April 1993
SMITHKLINE AGREEMENT
12 April 1993
FRENCH MOVES ON VIRAL DISEASES
8 March 1993
FDA APPROVES 26 NEWDRUGS IN 1992
25 January 1993
PERTUSSIS VACCINE IN ADULTS
4 January 1993
DECEMBER MEETING OF EURO CPMP
21 December 1992
HEALTH CARE NEEDS IN CENTRAL ASIA
29 June 1992
EC CPMP MEETING RELEASES SPC GUIDELINES
29 June 1992
SB SIGNS TWO VACCINES DEALS
22 June 1992
WHA HEARS WHO REPORT ON WORLD HEALTH
18 May 1992
MERCK & MERIEUX VACCINE DEAL
27 April 1992
SUSPENSION OF DPT VACCINE
13 April 1992
SUSPENSION OF DPT VACCINE
13 April 1992
UK DTP VACCINATION SCHEDULE
9 March 1992
VIETNAM DRUG PRICING, VACCINES
20 January 1992
"EARLY SUCCESS" FOR UK NHS REFORMS
20 January 1992
US APPROVES TAKEDA PERTUSSIS VACCINE
6 January 1992
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Elan puts up formal "for sale" notice
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
